In colon cancer cells, upregulation of LPAR2 and LPAR4 helps to overcome the oxidative stress induced by H2O2 and anticancer drugs such as 5′-fluoro-uracil, irinotecan and oxaliplatin [133]. Here, LPAR2 is linked to malignant colon neoplasm.